SURVIVAL IN CANCER CLINICAL TRIALS- A COMPARISON OF EMA APPROVALS AND NICE RECOMMENDATIONS.
Author(s)
Filby A1, Edwards HK1, Beggs L1, O'Brien S2
1National Institute for Health and Care Excellence, Manchester, UK, 2Newcastle University, Newcastle, UK
OBJECTIVES: Davis et al. (BMJ
Conference/Value in Health Info
2018-11, ISPOR Europe 2018, Barcelona, Spain
Value in Health, Vol. 21, S3 (October 2018)
Code
PCN310
Topic
Health Technology Assessment
Topic Subcategory
Decision & Deliberative Processes
Disease
Oncology
Your browser is out-of-date
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now